FTRE NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Fortrea Holdings Inc. · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 19.17 USD
-1.8% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 38.1% above the Trend Line and sits at 85.7% of its 52-week range. The latest completed week returned -1.8%, after a 10.9% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 55/100 conviction, while the latest news-sentiment score is 54/100. Near-term considerations: earnings are due in 3d.

Setup score 68 out of 100
Latest Close 19.17 USD 31 Jul 2026
1W Return -1.8% latest completed week
4W Return 10.9% short-term follow-through
12W Return 24.2% quarterly tape
Trend Breadth 51.9% 27 of 52 weeks active
Volume Ratio 1.6x vs 13-week average
What is working
  • The trend backdrop is active with a 4-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • No major top-level risk cluster is currently dominant.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -1.8% Latest completed week; four-week move 10.9%. Indicator stack 42/70 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 57.60% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 55/100 conviction; expected move 14.5%. News sentiment 54/100 39 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 38.1% above the Trend Line and sits at 85.7% of its 52-week range. The latest completed week returned -1.8%, after a 10.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8212-week average 0.53

12-week confirmation

Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.82Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 10.9% over four weeks, 24.2% over 12 weeks, and 251.1% over one year. The current trend has remained active for 4 consecutive weeks.

Performance by holding period

1W-1.8%
4W10.9%
12W24.2%
26W14.0%
52W251.1%
Active trend streak4 weeks
Active weeks in one year27
Trend breadth51.9%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.00Latest activity-pressure read.
Pressure change19.4%Four-week change in activity pressure.
Leadership38.32Latest relative-leadership reading.
RS change34.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength81/100Blend of value, momentum, and quality. Underlying universe rank 20; rank 1 is best.
Value72/100Relative valuation strength. Underlying universe rank 29; rank 1 is best.
Quality17/100Profitability and accounting quality. Underlying universe rank 84; rank 1 is best.
Momentum98/100Medium-term price momentum. Underlying universe rank 3; rank 1 is best.
Growth27/100Revenue and earnings growth. Underlying universe rank 74; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.7x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
8.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
16.0%
Gross profit retained from each unit of revenue.
Operating margin
-13.3%
Operating profit retained from revenue.
Free-cash-flow margin
9.3%
Free cash flow generated from revenue.
Return on invested capital
-18.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
0.9%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
32.3%
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-3.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

FTRE shows volatility options pressure with a 55/100 conviction score, put-call volume ratio of 0.03, expected move of 14.5%, and Sharemaestro trend signal active.

Conviction55/100
Expected move14.5%
Put/call volume0.03
Pressure100
Speculation1
Volatility96
Trend agreement13
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment54/100

Weighted news tone is neutral across 39 relevant articles.

10 positive · 26 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move14.5%Nearest-chain priced movement where available.
52-week drawdown-10.4%Distance below the 52-week high.
13-week volatility10.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2613 weeks finished lower.
Best week+26.7%Week of 8 May.
Worst week-33.2%Week of 13 Feb.
Latest week-1.8%Week of 31 Jul.

Shape of recent returns

Strong gains10
Modest gains2
Flat weeks1
Modest losses5
Sharp losses8
Recent vol10.1%13-week weekly-return volatility.
Base vol11.5%52-week weekly-return volatility.
Up/down split29/22Count of positive and negative weeks in the 52-week window.
Average skew11.1% / -7.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape63/100

Trend, activity pressure, participation, and risk combine to a 63/100 tape read.

 Indicator analysis72/100

Latest 12-week confirmation: trend 4/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.82; No reversal markers Next-Week ExpectancyPositive 57.60%

Next-week expectancy is positive with a 57.60% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors65/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 57; Small Cap Core rank 42 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options40/100

FTRE shows volatility options pressure with a 55/100 conviction score, put-call volume ratio of 0.03, expected move of 14.5%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 14.5% Sentiment54/100

Weighted news tone is neutral across 39 relevant articles.

Fortrea (NASDAQ:FTRE) Raised to Hold at William Blair Insiders50/100

No recent insider transaction evidence is stored.

 Earnings3d

Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202619.17 USD-1.8%13.88 USD19.12 USD1.0038.3211.7MOn
24 Jul 202619.52 USD9.9%13.81 USD19.19 USD0.8144.096.4MOn
17 Jul 202617.76 USD0.0%13.73 USD19.27 USD0.8431.115.1MOn
10 Jul 202617.76 USD2.8%13.73 USD19.37 USD0.8327.824.8MOn
3 Jul 202617.28 USD-2.1%13.67 USD19.46 USD0.8428.585.2MOff
26 Jun 202617.65 USD15.3%13.56 USD19.56 USD0.9034.5010.9MOff
19 Jun 202615.31 USD-7.1%13.40 USD19.57 USD0.7513.286.5MOff
12 Jun 202616.48 USD2.5%13.25 USD19.60 USD0.6726.605.3MOff
5 Jun 202616.08 USD4.5%13.05 USD19.62 USD0.5727.968.1MOff
29 May 202615.39 USD16.4%12.89 USD19.64 USD0.5418.595.5MOff
22 May 202613.22 USD-3.2%12.73 USD19.67 USD0.396.284.8MOff
15 May 202613.66 USD-11.5%12.66 USD19.71 USD0.0612.455.6MOff
8 May 202615.43 USD26.7%12.52 USD19.75 USD-0.2628.1512.3MOff
1 May 202612.18 USD24.3%12.33 USD19.78 USD-0.777.839.8MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.